Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-09

Clinical Trial Update: Sildenafil Citrate for Treatment of Growth-restricted Fetuses [Phase 3]

View source ↗

Summary

Update on a Phase 3 trial evaluating sildenafil citrate for fetal growth restriction; the document does not provide results and the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sildenafil citrate (Sildenafil citrate)

Snippet

Sponsor: Ain Shams University | Conditions: Fetal Growth Restriction | Phase 3 | Status: UNKNOWN